Adaptive Biotechnologies ADPT Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's accrued liabilities, current?
- Adaptive Biotechnologies (ADPT) reported accrued liabilities, current of $7.47M in Q1 2026.
- How has Adaptive Biotechnologies's accrued liabilities, current changed year-over-year?
- Adaptive Biotechnologies's accrued liabilities, current decreased by 3.8% year-over-year, from $7.76M to $7.47M.
- What is the long-term trend for Adaptive Biotechnologies's accrued liabilities, current?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's accrued liabilities, current has grown at a -10.2% compound annual growth rate (CAGR), from $13.16M to $7.7M.